Abstract. Sheep scrapie is a prion disease that requires interaction of exogenous prions with host prion protein (PrP) supporting prion formation. Disease is associated with deposition of a host-generated conformational variant of PrP, PrP sc , in a variety of tissues, including brain, resulting in fatal spongiform encephalopathy. Efficiency of PrP sc formation is determined by polymorphisms in the PrP-coding sequence. This article adds to previous data of natural sheep scrapie, concentrating on the effect of host genotype and age on PrP sc accumulation patterns during preclinical and clinical disease. Two entire scrapie-infected, predominantly Suffolk-cross, sheep flocks euthanized for regulatory purposes were genotyped and analyzed for PrP sc deposition in various tissues using single-and dual-label immunohistochemistry. Scrapie, as defined by PrP sc deposition, occurred in 13/80 sheep. Preclinical disease was evident in nearly 70% of infected sheep, ranging in age from 14 months to 7 years. PrP sc accumulated systemically in the nervous tissue, various lymphoid tissues, both alimentary tract related and non-alimentary tract related, and the placenta. Clinical neurological illness was always associated with spongiform encephalopathy and PrP sc deposition in the brain. Only 6 of 9 sheep with preclinical scrapie had PrP sc deposition in the brain but widespread PrP sc deposition in peripheral lymphoid tissue, supporting previous data showing peripheral PrP sc accumulation preceding deposition in the brain. PrP sc colocalized with a marker for follicular dendritic cells throughout the lymphoid system. PrP sc also accumulated in the peripheral nervous system, particularly the nervous supply of the gastrointestinal tract. Abundant PrP sc was evident in trophoblast cells of placentomes but not in the endometrium, myometrium, or associated nervous plexus. PrP sc deposits were not observed in the mammary parenchyma or bone marrow. Scrapie susceptibility was defined genetically by PrP codon 171: PrP sc deposition was restricted to PrP genotype AA 136 RR 154 QQ 171 in 12/13 cases or AV 136 RR 154 QQ 171 in 1/13 cases. The earliest accumulation was observed in the single VRQ/ARQ heterozygous animal, consistent with the reported high scrapie susceptibility and brief incubation period observed in breeds with predominance of the V 136 R 154 Q 171 allele. Disease occurred within, as well as independent of, motherdaughter lines, suggesting both maternal and nonmaternal transmission in the flocks.
Introduction
Scrapie is the prototype of those transmissible spongiform encephalopathies (TSE) with a combined infectious and genetic pathogenesis and occurs naturally in sheep and goats. [10] [11] [12] The importance of oral uptake of infectious material for transmission 12, 29, 30 and the contribution of lymphoid tissue related to the alimentary tract for local amplification of PrP sc , a conformational variant of prion protein (PrP), have been recognized 12, 18 and is supported by experimental models. 3, 4 Data indicate that scrapie generally follows oral uptake of prions and includes a preclinical phase characterized by local amplification of PrP sc in the lym-phoid tissue of the alimentary tract and transport through the peripheral nervous system into the central nervous system (CNS). 8, 13, 14 PrP sc accumulation patterns vary greatly among prion diseases, and susceptibility to scrapie is greatly modified by polymorphisms in the PrP gene, PRNP. This article, in support of previous reports, describes the biology of natural scrapie in 2 sheep flocks with specific reference to the tissue and cellular topography of PrP sc during preclinical and clinical disease, the role of host genotype in disease incubation, and potential modes of agent transmission.
Materials and methods
Animals and selection of tissue samples. Sheep (n ϭ 80) from 2 privately owned flocks were euthanized and necropsied for disease regulatory purposes after observation of index clinical scrapie cases. Flock A, containing 50 sheep, originated from North Central United States, and flock B, containing 30 sheep, originated from the Pacific Northwest United States. Both flocks consisted predominately of Suffolk (n ϭ 51) or Suffolk-cross sheep (n ϭ 22), with the remainder being Black desert (n ϭ 3) or White desert (n ϭ 4). Sheep ranged in age from 12 mo to Ͼ6 yr, the majority being Յ2 yr old (n ϭ 54). Information on clinical signs and familial lineage was collected for individual sheep. Various tissues were collected postmortem and fixed in 10% formalin for analysis of microscopic lesions by histopathology and PrP sc deposition by immunohistochemistry. Anatomic sites of tissues for PrP sc immunohistochemistry were 1) CNS (brain), 2) alimentary tract (jejunum, ileum, colon, rectum) and related lymph nodes, 3) lymphoid system not related to the alimentary tract (third eyelid, spleen, and various lymph nodes [superficial cervical, subiliac, medial iliac]), 4) mammary gland and related lymph node, 5) hematopoietic tissues (bone marrow), and 6) reproductive/fetal tissues (uterus, placenta, fetal spleen, fetal ileum).
Determination of PrP genotype. Whole blood was collected for isolation of genomic DNA from the leukocyte fraction. Amino acid polymorphisms at PrP codons 136, 154, and 171 were determined by DNA sequencing using commercially available services. a,b DNA sequencing followed PCR amplification using primers specific for the entire PrPcoding sequence, as described previously. 38 Immunohistochemical detection of PrP sc . Single-label immunohistochemistry for PrP sc was performed on formalinfixed, paraffin-embedded tissues using heat-induced antigen retrieval and 90% formic acid pretreatment as described previously. 25 F89.160.1.5 (F89), a monoclonal antibody (mAb) to ruminant PrP targeting a conserved epitope at residues 142 through 145 of ovine PrP, 26 was used at a concentration of 1 g/ml in a labeled streptavidin-biotin-based system. c Amino-ethyl-carbazole (AEC) was used as a chromogen. d Positive control tissue, consisting of brain or lymph node from a known scrapie-positive sheep, was included in each run to confirm immunoreactivity of the appropriate pattern and intensity in lymphoid follicle germinal centers and in the neuropil of the brain as described previously. 26, 27 Negative controls consisted of a negative antibody control and a negative tissue control. Negative antibody was an irrelevant isotype-matched primary antibody (anti-Neospora caninum mAb Nc-5B6-25, 1 g/ml) reacted with each test slide to ensure the lack of nonspecific binding by linker or signal amplification reagents to tissue sections. Negative tissue control consisted of brain and lymph node of a known scrapie-negative sheep reacted with anti-PrP mAb F89 to ensure absence of PrP sc immunoreactivity.
Conditions of antigen retrieval and pretreatment procedures were adapted for dual immunohistochemistry using antibodies toward cell-specific markers in conjunction with F89 for PrP sc . Antibodies toward cell markers included mAb CNA.42 for follicular dendritic cells (FDCs), e anti-CD3 rabbit antiserum for T lymphocytes, d anti-CD79a mAb for B lymphocytes, e anti-neuron-specific enolase rabbit antiserum for ganglion cells, d and mAb NCL-LN5 for macrophage/ monocytes. f Dual labeling was carried out sequentially using cell-specific antibodies with peroxidase-based color reaction (red) in the first sequence and F89 with alkaline phosphatase-based color reaction (black) in the second sequence. After development of the red signal (AEC) under microscopic control, slides were incubated with 0.3 M glycine HCl at pH 1.8 at room temperature overnight to denature potential binding sites on linker reagents from the first sequence; then, residual biotin binding was blocked with an avidinbiotin-blocking kit. g As a control for the efficacy of blocking steps between sequences (i.e., nonspecific staining of the second immunostaining sequence), slides were treated with the full first sequence except for the color reaction and then subjected to the blocking steps and the full second sequence omitting primary antibody incubation. Absence of black signal (second signal) in these slides indicated effectiveness of disruptive glycine HCl treatment and avidin-biotin block between the sequences and, thus, absence of cross-reactivity between the 2 sequences (i.e., black signal represented PrP sc without cross-reactivity with cell markers).
Results
Age distribution of PrP sc accumulation. Age of the sheep ranged from 12 months to 7 years of age; 67% of sheep were 24 months or younger (Table 1) . Scrapie, as defined by neural or extraneural deposition of PrP sc , was diagnosed in 13 of 80 sheep (16.25%), whereas 67 of 80 sheep (83.75%) had no detectable Clinical neurological disease typical of scrapie was observed in 4 of the 13 sheep with PrP sc deposits. PrP sc deposits and spongiform lesions were widespread within the 4 coronal planes examined (brain stem at the obex, middle cerebellar peduncle, rostral mesencephalic colliculi, and thalamus). The remaining 9 sheep with PrP sc deposits were preclinical and ranged in age from 14 months to more than 6 years.
Tissue distribution of PrP sc deposition. PrP sc deposits were widespread in all scrapie-infected sheep (Table 2). Detection of PrP sc in non-central nervous tissues was biased by the density of lymphoid follicles in the examined sample. For example, deposits were more frequently observed in ileum and colon (12 of 13 samples) than in rectum and jejunum (7 of 13 and 9 of 12 samples, respectively).
PrP sc deposits in the brain were detected in all (4 of 4) clinical sheep, but only in 6 of 9 preclinical sheep. Central nervous deposits were thus less frequent (10 of 13; 77% of affected sheep) than alimentary tractrelated deposits (13 of 13; 100%). Deposits in extraneural tissue always accompanied PrP sc deposits in the brain.
PrP sc deposits were generalized in alimentary tractassociated and non-alimentary tract-associated lymphoid tissue. PrP sc deposits occurred in the placentas of 8 of 9 scrapie-infected sheep that were pregnant. Of the 8 placenta-positive ewes, 6 were preclinical, 2 of which were without deposits in the brain. PrP sc was not detected in the bone marrow, secretory parenchyma of the mammary gland, uterus, or fetus of any scrapie-infected sheep.
Cellular distribution of PrP sc deposition. In lymphoid tissues, PrP sc deposits were localized to the germinal centers of lymphoid follicles in a random, multifocal pattern (Fig. 1A) . Cells that accumulated PrP sc in lymphoid tissues were similar regardless of the anatomical location of the lymphoid tissue. The intensity ← enteric lymph node (preclinical). Higher magnification of PrP sc (black) colocalized (arrows) with dendrites and cell bodies of FDCs (red). Dual-label immunohistochemistry using CNA.42-red (FDC) and F89 mAb-black (PrP sc ). 630ϫ. D, ileum (clinical). Finely granular deposits of PrP sc (black) occur throughout the myenteric plexus (red). Colocalization (arrows) of PrP sc (black) with nerve fibers of the myenteric plexus (red). Dual-label immunohistochemistry using anti-neuron-specific enolase-red (ganglia neurons and fibers) and F89 mAb-black (PrP sc ). 100ϫ. E, medial iliac lymph node germinal center (clinical). PrP sc deposits (black) do not colocalize with T lymphocytes (red) that are sparsely scattered throughout the germinal center (G) or packed within the adjacent paracortex (P). Dual-label immunohistochemistry using anti-CD3-red (T-lymphocyte) and F89 mAb-black (PrP sc ). 400ϫ.
F, subiliac lymph node germinal center (clinical). PrP sc (black) does not colocalize with B lymphocytes (red) in the germinal center (G). Dual-label immunohistochemistry using anti-CD79a-red (B-cell) and F89 mAb-black (PrP sc ). 400ϫ. G, placenta (placentome) (clinical). PrP sc (red) localized to chorionic epithelium of the fetal cotyledon (arrows). No immunoreactivity of maternal caruncle epithelium (M). Single-label immunohistochemistry using F89 mAb-red (PrP sc ). 200ϫ. H, placenta (placentome) (clinical). PrP sc (red) localized to the cytoplasm of mononuclear and multinuclear chorionic epithelial cells of the fetal cotyledon (arrows). Some immunoreactivity free in the extracellular space between fetal cotyledon and maternal caruncle (arrowhead).
Single-label immunohistochemistry using F89 mAb-red (PrP sc ). 630ϫ.
of immunoreactivity varied among individual sheep but did not correlate with age or clinical status. Most immunoreactivity was detected in multipolar cells characteristic of FDCs (Fig. 1B) . Using dual-label immunohistochemistry, detecting specific cellular markers and PrP sc , PrP sc colocalized with CNA.42, a marker specific for FDC (Fig. 1B, 1C) . 19, 22, 33 PrP sc did not colocalize with CD3, a marker for T lymphocytes (Fig.  1E) , or CD79a, a B-lymphocyte marker (Fig. 1F) . Rarely, PrP sc colocalized with a macrophage marker (NCL-LN5) in macrophages in the medulla of lymph nodes but not within germinal center macrophages (not shown). PrP sc deposition in nonlymphoid tissues (outside the CNS) was restricted to neurons and chorionic epithelium. In the gut, PrP sc was regularly detected within the perikarya and neurites of the submucosal and myenteric plexus, colocalizing with neuron-specific enolase, a marker for neural cells (Fig. 1D ). Axonal and somatic PrP sc deposits were also detected in the mesenteric ganglia (not shown). No PrP sc deposits were detected in gut epithelial cells, including M cells of Peyer's patches, smooth muscle cells, endothelial cells, or round cells in the lamina propria. Placental PrP sc deposition was present multifocally in placentomes within groups of chorionic epithelial cells of the cotyledon but not within adjacent endometrial epithelial cells of the interdigitating maternal caruncle (Fig. 1G) . The deposits were present within the cytoplasm of chorionic mononuclear and multinuclear trophoblast cells (as identified by morphology) and were apparently not cell associated in the space between the fetal cotyledon and the maternal caruncle (Fig. 1H) . In the brain, PrP sc deposits were associated with glial cells and neurons within various nuclei of the diencephalon, mesencephalon, metencephalon, and myelencephalon. Detailed, scrapie strain-specific topography of central nervous PrP sc deposits has been reported 9 and was not the subject of this study.
Effect of PrP genotype on scrapie status of the sheep. All PrP sc -positive sheep were homozygous for glutamine at codon 171 and homozygous for arginine at codon 154 of the PrP gene (RR 154 QQ 171 ) ( Table 3) (Table 3) .
Potential modes of transmission. Potential modes of scrapie transmission were investigated by analyzing genealogy within flock A and by examining fetuses and offspring of PrP sc -positive sheep when available. Association of clinical scrapie with PrP sc -positive status by genealogy was not possible in all PrP sc -positive sheep. Not all sheep culled or removed from the flocks because of wasting of suspect scrapie were necropsied to definitively determine scrapie status. However, in 7/ 13 PrP sc -positive sheep, in which accurate genealogy analysis was possible, positive scrapie status followed mother-to-daughter lineage in 57% (4/7) and was not associated with mother-to-daughter lineage in 43% (3/ 7). The single 7-year-old sheep with preclinical scrapie was part of the latter group. Two fetuses from PrP scpositive ewes with clinical scrapie were available for examination. Both ewes had PrP sc deposition in the placenta, proving the scrapie-susceptible genotype of the fetus, 36 but neither fetus had PrP sc deposition in fetal spleen or intestine ( Table 2) .
Discussion
This study demonstrates the spatial and cell-specific preclinical accumulation pattern of PrP sc in sheep that resemble in their PrP genotype the American Suffolk, a breed with limited PrP gene polymorphism and prolonged preclinical phase. As expected from experimental models, 4,5,23 a buildup of PrP sc throughout the lymphoid system can be observed during the preclinical period after a lag phase during which PrP sc is not detectable by immunohistochemistry. After the lag phase, PrP sc accumulates rapidly in lymphoid tissues throughout the body as well as the intestinal nervous supply, which offers the possibility of biopsy-based preclinical diagnosis. 24, 25, 34, 35 On the other hand, preclinical dissemination of PrP sc deposits into the placenta indicates a risk of horizontal and vertical transmission by clinically healthy ewes. The finding that most cases within scrapie-affected flocks are preclinical underscores the significance of observing PrP sc accumulation in the placentas of a high percentage of infected sheep.
Based on this study, the lag phase needed for PrP sc deposits to become detectable by immunohistochemistry is about 12-14 months, assuming perinatal infection by oral exposure to PrP sc . This lag phase is longer in Suffolk-type sheep with predominance of the A 136 R 154 Q 171 allele than the 2-6 months reported in breeds with predominance of the V 136 R 154 Q 171 allele. 1, 21, 35 The data thus support the notion that the primary structure of PrP determines the rate of PrP sc accumulation. From this it follows that the residues at positions 136 and 171 determine disease susceptibility by altering accumulation kinetics rather than accumulation sites or cellular specificity. Further research is needed to determine the nature of this kinetic barrier and whether parameters such as time and infectious dose modify its permissibility to accumulation and disease.
PrP sc was identified in FDCs and peripheral neurons. PrP sc was only rarely detected in macrophages. Scant, macrophage-associated PrP sc was occasionally detected in the medulla of lymph nodes, rather than in the germinal centers of lymphoid follicles. This observation contrasts somewhat to a similar study that reports early accumulation of PrP sc in tingible body macrophages of the germinal center. 17 Failure to observe PrP sc in tingible body macrophages may be because of examination of tissues at a later stage of disease because PrP sc derives from scavenging exogenous PrP sc rather than synthesis within that cell type. 15 The distribution of PrP sc observed in this study underscores the importance of the germinal center and FDC for the peripheral amplification of PrP sc and is consistent with neurogenic spread from sites of primary amplification to the CNS. Our observations support the role of FDC for scrapie pathogenesis 6 and are in line with experiments that report drastically reduced susceptibility of mice to scrapie on dedifferentiation of FDC. 20 Furthermore, the proximity of nerve endings and PrP sc in lymphoid follicles has been demonstrated. 14, 31 Conversely, in this study the authors failed to observe a pattern of PrP sc accumulation in lymphoid tissues that would suggest travel of PrP sc through the lymphatic vessels or blood stream. For instance, PrP sc was not detected in the glandular tissue of the mammary gland, the tributary region of the mammary lymph nodes; yet, the mammary lymph node regularly accumulated PrP sc . Likewise, PrP sc was not detected in the bone marrow or splenic red pulp and was only rarely detected in macrophages within lymph nodes. The mode by which generalized depositional disease throughout the lymphoid tissue is initiated and synchronized has been elusive; however, episodic hematogenous dispersion of cells carrying PrP sc below the detection level of immunologic assays is a possibility.
Large, intrauterine PrP sc deposits occurred during preclinical and clinical disease and were restricted to the (fetal) chorionic epithelium of the placentome, whereas no PrP sc was detected in adjacent maternal tissues or tissues of the fetus proper. This observation is consistent with the well-recognized infectivity of fetal membranes. 32 Similar to Andreoletti et al., 2 PrP sc was found to be restricted to fetal tissues. Because placentomes were not analyzed specifically for macrophages, the possibility of PrP sc deposits occurring in macrophages of the (maternal) caruncle or at the interface between fetal and maternal tissues remains.
The finding of Andreoletti et al. 2 is in contrast to those of Tuo et al., 37 who observed PrP sc deposits also in the caruncular epithelium, albeit the latter study did not use double immunohistochemistry to ascertain cellular specificity Natural transmission of sheep scrapie is thought to occur most commonly by perinatal maternal transmission through oral exposure of neonates to prions within the secundines and placental fluids, 7,32 a mechanism supported by the findings of this study. Infection of placental membranes is reportedly restricted to susceptible fetal genotypes. 36 In this study, transmission followed ewe-to-lamb lines in most scrapie-affected sheep, and there was abundant PrP sc deposition within and around placental trophoblast cells. PrP sc was not evident in 2 genetically susceptible fetuses, supporting other studies arguing against direct intrauterine transmission of scrapie or infectivity of the fetus proper. 2, 12 However, horizontal transmission is reported to occur in heavily infected flocks. 39 Similarly, this study showed transmission outside the ewe-to-lamb lines in 43% of cases; for example, preclinical scrapie was diagnosed in a 7-year-old ewe. Understanding how PrP polymorphism affects PrP conversion and PrP sc deposition in specific tissues and cell types, especially those at potential sites of preclinical accumulation, is critical to the development of treatment or control measures for the scrapie-type TSE.
